Treatment withdrawal · people with neurosyphilis
It is very uncertain whether ceftriaxone changes withdrawals compared with penicillin G (very low certainty).
1 finding from 1 review
Death ‐ in all participants ‐ short term · people suspected to have meningococcal disease (adults and children)
Ceftriaxone showed no clear difference in death ‐ in all participants ‐ short term compared with long‐acting (oily) chloramphenicol (moderate certainty).
1 finding from 1 review
Death ‐ in confirmed cases of meningococcal meningitis (subgroup) · people suspected to have meningococcal disease (adults and children)
Ceftriaxone showed no clear difference in death ‐ in confirmed cases of meningococcal meningitis (subgroup) compared with long‐acting (oily) chloramphenicol (moderate certainty).
1 finding from 1 review
Clinical failure ‐ in all participants ‐ short term Composite clinical criteria10 · people suspected to have meningococcal disease (adults and children)
Ceftriaxone showed no clear difference in clinical failure ‐ in all participants ‐ short term Composite… compared with long‐acting (oily) chloramphenicol (moderate certainty).
1 finding from 1 review
Clinical failure ‐ in confirmed cases of meningococcal meningitis (subgroup) Composite clinical criteria10 · people suspected to have meningococcal disease (adults and children)
Ceftriaxone showed no clear difference in clinical failure ‐ in confirmed cases of meningococcal meningitis… compared with long‐acting (oily) chloramphenicol (moderate certainty).
1 finding from 1 review
Neurological sequelae ‐ in all participants‐ short term Clinical assessment11 · people suspected to have meningococcal disease (adults and children)
Ceftriaxone showed no clear difference in neurological sequelae ‐ in all participants‐ short term Clinical… compared with long‐acting (oily) chloramphenicol (low certainty).
1 finding from 1 review
Neurological sequelae ‐ in confirmed cases of meningococcal meningitis (subgroup) Clinical assesment11 · people suspected to have meningococcal disease (adults and children)
It is very uncertain whether ceftriaxone changes neurological sequelae ‐ in confirmed cases of meningococcal… compared with long‐acting (oily) chloramphenicol (very low certainty).
1 finding from 1 review
Adverse events ‐ short term · people suspected to have meningococcal disease (adults and children)
1 finding from 1 review
Cure of gonococcal infection (microbiological culture) · pregnant women with gonorrhoea infection
It is very uncertain whether intramuscular ceftriaxone changes cure of gonococcal infection (microbiological culture) compared with oral amoxicillin plus oral probenecid (very low certainty).
1 finding from 1 review
Adverse events including treatment‐related adverse events · pregnant women with gonorrhoea infection
1 finding from 1 review
Incidence of obstetric complications · pregnant women with gonorrhoea infection
1 finding from 1 review
Incidence of disseminated gonococcal infection · pregnant women with gonorrhoea infection
1 finding from 1 review
Neonatorum ophthalmia · pregnant women with gonorrhoea infection
1 finding from 1 review
Adverse events including treatment‐related adverse events · pregnant women with gonorrhoea infection
It is very uncertain whether intramuscular ceftriaxone changes adverse events including treatment‐related adverse events compared with oral amoxicillin plus oral probenecid (very low certainty).
1 finding from 1 review
Cure of gonococcal infection (microbiological culture) · pregnant women with gonorrhoea infection
It is very uncertain whether intramuscular ceftriaxone changes cure of gonococcal infection (microbiological culture) compared with oral cefixime (very low certainty).
1 finding from 1 review
Incidence of obstetric complications · pregnant women with gonorrhoea infection
1 finding from 1 review
Incidence of disseminated gonococcal infection · pregnant women with gonorrhoea infection
1 finding from 1 review
Neonatorum ophthalmia · pregnant women with gonorrhoea infection
1 finding from 1 review
All‐cause mortality during hospital stay and all‐cause mortality at 1 year · people with infective endocarditis due to penicillin‐susceptible Streptococci
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cure · people with infective endocarditis due to penicillin‐susceptible Streptococci
Beta‐lactam (ceftriaxone) plus aminoglycoside (gentamicin) showed no clear difference in cure compared with beta‐lactam (ceftriaxone) (low certainty).
1 finding from 1 review